WHO ICTRP trial

Effect of Propolis in patients with Angina

RBR-876w38c · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Recruiting

Key facts

Trial ID RBR-876w38c
Public title Effect of Propolis in patients with Angina
Scientific title Effect of Green Propolis Extract (EPP-AF) in patients with Chronic Stable Angina. A randomized, blinded pilot study
Primary sponsor Hospital Ana Nery
Secondary sponsors Hospital Ana Nery
Registry Registro Brasileiro de Ensaios Clinicos (ReBEC)
Recruitment status Recruiting
Study type Intervention
Countries Brazil
Conditions Angina pectoris
Interventions This is a two-arm, double-blind, randomized controlled clinical trial. Patients included in the study will be randomized (2:1) to use a propolis tablet (at a dose of 500mg/day) or an inert placebo. Experimental group: 40 individuals with…
Registration date Aug 8, 2022
Registry page ensaiosclinicos.gov.br

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations